Cerebral palsy is a lifelong disorder caused by damage to a
childâ€™s brain before, during, or shortly after birth. Symptoms vary in severity and include stiff muscles, involuntary
movements, or cognitive deficits.
Some children are able to function quite normally, while others will
require continued care throughout their lives.
According to Healthcare Global, recent research suggests the use of a new drug that might
limit the development of cerebral palsy if administered early enough.
One of the hypothesized causes of cerebral palsy is that the
brain damage is a result of inflammation in the childâ€™s brain; this
inflammation stems from an infection during pregnancy. In a recent research study, rabbits
with similar characteristics of cerebral palsy were administered a drug that
targets and treats the inflammation in the brain. The rabbits who were treated showed much better muscle and
movement control than the rabbits who did not receive the drug.
If the new drug works for humans as well as it did for the
rabbits, it could be a very promising treatment for brain damage caused by
prenatal infections. There have
been no human clinical trials or an examination of side effects. Researchers say the drug must be
administered right after birth in order to be effective.